Believe Big Announces 3rd Annual Dinner to Help Johns Hopkins Hospital Kiss Cancer Goodbye

Believe Big's 3rd annual dinner will not only raise the remaining funds for the phase 1 mistletoe clinical trial in collaboration with Johns Hopkins Hospital, but awareness to change the way cancer is thought of and treated in the United States.

Baltimore, MD (PRWEB) March 13, 2014

Believe Big will hold its 3rd Annual fundraising dinner on Saturday, May 10th at the Renaissance Harborplace Hotel. It will be an evening of inspiration, celebration and education. Guests will hear the latest information on the groundbreaking mistletoe clinical trial in collaboration with Johns Hopkins Hospital.

There will be inspiring stories from cancer patients on the impact Believe Big is having on their cancer journey and speakers will discuss the importance of a combined approach (conventional & complementary) to fighting and overcoming cancer. An opportunity to make a financial gift to Believe Big and the clinical trial will be provided at the dinner.

Mistletoe therapy is used widely in Europe for cancer treatment. European oncologists have used extracts of mistletoe for close to a century and currently one out of every three oncologists in Germany prescribe mistletoe.

Mistletoe extract can be used in malignant and non-malignant tumors, for stimulation of bone marrow activity, to diminish tumor-related pain, increase the immune response, prevent a recurrence during the watchful waiting period, and offset the terrible side affects of chemotherapy—nausea, vomiting, and lack of appetite.

Believe Big founder, Ivelisse Page, was cured of her stage 4 colon cancer by having a comprehensive approach to her treatment. She combined both complementary (mistletoe extract, homeopathy, and a high alkaline diet) and conventional treatments (surgery, scans, blood work). She is now 5 years cancer free.

Now Believe Big and Johns Hopkins Hospital are collaborating on a mistletoe clinical trial that brings the conventional and complementary medical communities together. Until a clinical trial is done in the United States, it can not be offered as standard of care. Johns Hopkins researchers say mistletoe treatment can change the way doctors go after cancer.

Dr. Luis Diaz, professor of oncology and senior researcher at Johns Hopkins, and Dr. Peter Hinderberger, expert in complementary medicine, both treated Ivelisse and are leading the clinical trial at Johns Hopkins Hospital.

This is truly a historic event as this clinical trial is patient driven and is being entirely funded by private donations. “We have 90% of the money needed to start Phase I of the trial. We are thrilled to be taking the first steps towards a cure for this devastating disease,” said Patty Buddemeyer, Assistant Director of Believe Big.

For more information about Believe Big and the 3rd Annual Dinner, visit http://www.believebig.org. Anyone wishing to be a part of this historic event can make a tax deductible donation to this trial by visiting http://www.gofundme.com/believebig-mistletoeTrial.


Contact

Attachments